Optometrists in Parkville, MO Accepting Medicare

5 Optometrists found. Showing 1 - 5

Dr. Nicole Dyan Verachtert, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6325 Lewis Dr, Suite 114, Parkville, MO 64152 Phone: 816-505-0100    Fax: 816-505-2301

Dr. Stephanie Anne Staatz, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6325 Lewis Dr Ste 114, Parkville, MO 64152 Phone: 816-505-0100    Fax: 816-505-2301

Dr. Rick J. Unsell Llc Optometrist - Corneal and Contact Management Medicare: Medicare Enrolled Practice Location: 7436 Nw River Park Dr, Parkville, MO 64152 Phone: 816-587-7327    Fax: 816-587-7328

The Eye Center Of Parkville Optometrist Medicare: Medicare Enrolled Practice Location: 6325 Lewis Dr, Ste 114, Parkville, MO 64152 Phone: 816-505-0100    Fax: 816-505-2301

Dr. Rick Jon Unsell, OD Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 7436 Nw River Park Dr, Parkville, MO 64152 Phone: 816-587-7327

News Archive

Study reveals increase of enzyme MAO-A in female brain during immediate postpartum period

Within the first week after giving birth, up to 70 percent of all women experience symptoms of the baby blues. While most women recover quickly, up to 13 percent of all new mothers suffer from symptoms of a clinical-level postpartum depression. Postpartum depression is defined as a major depressive episode starting within 4 weeks after delivery and is a significant public health problem. Postpartum blues represents a major risk factor for developing postpartum depression and severe postpartum blues symptoms can be viewed as a prodromal stage for postpartum depression.

Researchers examine link between tumor mutational burden and response to immune checkpoint therapy

Predicting how patients will respond to anti-cancer therapies can be vital in informing clinical decisions and improving treatment outcome.

Researchers identify how obese people become salt sensitive, hypertensive

One way obese people become salt sensitive and hypertensive has been identified by Medical College of Georgia researchers.

Omeros gets regulatory clearance to begin Phase 1 clinical trial of OMS721

Omeros Corporation today announced that it has obtained regulatory clearance to start the Phase 1 clinical trial evaluating OMS721, the Company's lead human monoclonal antibody from its mannan-binding lectin-associated serine protease-2 (MASP-2) program.

First extensive review of COVID-19's effects on all affected organs outside the lungs

After only a few days caring for critically ill COVID-19 patients at the start of the outbreak in New York City, Aakriti Gupta, MD, realized that this was much more than a respiratory disease.

Read more Medical News

› Verified 5 days ago